(Q34526158)

2 August 2017

Impaired oxidation of debrisoquine in patients with perhexiline liver injury (English)

1 reference

2 August 2017

0 references

M Y Morgan

1

1 reference

2 August 2017

R Reshef

2

1 reference

2 August 2017

R R Shah

3

1 reference

2 August 2017

N S Oates

4

1 reference

2 August 2017

R L Smith

5

1 reference

2 August 2017

S Sherlock

6

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 October 1984

1 reference

2 August 2017

1 reference

2 August 2017

25

1 reference

2 August 2017

1057-1064

1 reference

2 August 2017

10

1 reference

Perhexiline maleate-associated hepatic injury prevalence and characteristics

2 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1432542

A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1432542

Assay and characterisation of debrisoquine 4-hydroxylase activity of microsomal fractions of human liver

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1432542

Impaired oxidation of debrisoquine in patients with perhexiline neuropathy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1432542

Perhexiline hepatitis and HLA-B8

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1432542

Letter: Secondary but reversible effects of perhexilin administration

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1432542

Subacute toxic hepatitis and perhexiline maleates

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1432542

Multiple complications of treatment with perhexiline maleate

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1432542

Proximal myopathy after perhexiline maleate treatment

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1432542

Perhexiline maleate-induced hepatitis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1432542

Liver cirrhosis after 2 years of perhexiline maleate treatment

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1432542

Hepatitis due to perhexiline maleate. Development of cirrhosis after interruption of the drug. Report of two cases (author's transl)

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1432542

Liver damage due to perhexiline maleate

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1432542

Acute hepatic failure due to perhexiline maleate

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1432542

Liver damage associated with perhexiline maleate

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1432542

Hepatitis caused by perhexiline maleate

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1432542

Anatomical documents concerning a fatal complication caused by a prolonged treatment with perhexiline maleate

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1432542

Perhexiline maleate-induced cirrhosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1432542

Diffuse polymorphous inclusions in a patient treated with perhexiline maleate (author's transl)

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1432542

Polymorphic hydroxylation of Debrisoquine in man.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1432542

Liver damage after perhexiline maleate

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1432542

The role of the hepatic microsomal ethanol oxidizing system (MEOS) for ethanol metabolism in vivo

7 July 2018

1 reference

12 December 2020

Long-term perhexiline maleate and liver function

1 reference

12 December 2020

Letter: Subacute toxic hepatitis following perhexiline maleate therapy

1 reference

12 December 2020

[Letter: Hepatitis medicamentosa caused by perhexiline]

1 reference

12 December 2020

Liver during perhexiline hypoglycaemia

1 reference

12 December 2020

Perhexiline maleate toxicity: a case of severe jaundice

1 reference

12 December 2020

Hepatic lesions due to perhexiline maleate (author's transl)

1 reference

12 December 2020

Polymorphism of carbon oxidation of drugs and clinical implications

1 reference

12 December 2020

Hepatotoxicity following treatment with perhexiline maleate

1 reference

12 December 2020

Identifiers

DOI

10.1136/GUT.25.10.1057

1 reference

2 August 2017

1 reference

2 August 2017

1 reference